189 related articles for article (PubMed ID: 15475457)
1. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
Wang H; Oliver P; Nan L; Wang S; Wang Z; Rhie JK; Zhang R; Hill DL
Cancer Chemother Pharmacol; 2002 May; 49(5):419-24. PubMed ID: 11976837
[TBL] [Abstract][Full Text] [Related]
3. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.
Li J; Kim S; Shields AF; Douglas KA; McHugh CI; Lawhorn-Crews JM; Wu J; Mangner TJ; LoRusso PM
J Clin Pharmacol; 2016 Nov; 56(11):1433-1447. PubMed ID: 27095537
[TBL] [Abstract][Full Text] [Related]
4. Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Sun H; Collins JM; Mangner TJ; Muzik O; Shields AF
Cancer Chemother Pharmacol; 2006 Feb; 57(3):343-8. PubMed ID: 16001172
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil).
Nimmagadda S; Mangner TJ; Lawhorn-Crews JM; Haberkorn U; Shields AF
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1987-93. PubMed ID: 19506865
[TBL] [Abstract][Full Text] [Related]
6. Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs.
Sun H; Collins JM; Mangner TJ; Muzik O; Shields AF
Nucl Med Biol; 2003 Jan; 30(1):25-30. PubMed ID: 12493539
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
[TBL] [Abstract][Full Text] [Related]
8. Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
Collins JM; Klecker RW; Katki AG
Clin Cancer Res; 1999 Aug; 5(8):1976-81. PubMed ID: 10473074
[TBL] [Abstract][Full Text] [Related]
9. Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
McHugh CI; Lawhorn-Crews JM; Modi D; Douglas KA; Jones SK; Mangner TJ; Collins JM; Shields AF
Cancer Imaging; 2016 Oct; 16(1):34. PubMed ID: 27751167
[TBL] [Abstract][Full Text] [Related]
10. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy.
Cai H; Li Z; Conti PS
Nucl Med Biol; 2011 Jul; 38(5):659-66. PubMed ID: 21718941
[TBL] [Abstract][Full Text] [Related]
11. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
Klecker RW; Katki AG; Collins JM
Mol Pharmacol; 1994 Dec; 46(6):1204-9. PubMed ID: 7808443
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression.
Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
Nucl Med Biol; 2004 May; 31(4):399-405. PubMed ID: 15093809
[TBL] [Abstract][Full Text] [Related]
13. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU).
Morgenroth A; Deisenhofer S; Neininger M; Vogg AT; Glatting G; Kull T; Reske SN
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):305-16. PubMed ID: 18432182
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.
Mangner TJ; Klecker RW; Anderson L; Shields AF
Nucl Med Biol; 2003 Apr; 30(3):215-24. PubMed ID: 12745012
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry.
Wiegand R; Wu J; Shields AF; Lorusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():64-70. PubMed ID: 22410089
[TBL] [Abstract][Full Text] [Related]
17. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
Sun H; Sloan A; Mangner TJ; Vaishampayan U; Muzik O; Collins JM; Douglas K; Shields AF
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):15-22. PubMed ID: 15586282
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.
Alauddin MM; Shahinian A; Gordon EM; Conti PS
Mol Imaging; 2004 Apr; 3(2):76-84. PubMed ID: 15296672
[TBL] [Abstract][Full Text] [Related]
19. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.
Jadvar H; Yap LP; Park R; Li Z; Chen K; Hughes L; Kouhi A; Conti P
Mol Imaging; 2012; 11(5):426-32. PubMed ID: 22954187
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs.
Nimmagadda S; Mangner TJ; Douglas KA; Muzik O; Shields AF
J Nucl Med; 2007 Apr; 48(4):655-60. PubMed ID: 17401105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
